Capricor Therapeutics Inc
F:4LN2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Capricor Therapeutics Inc
F:4LN2
|
US |
|
Maxell Ltd
TSE:6810
|
JP |
|
N
|
Northern Trust Corp
SWB:NT4
|
US |
Multiples-Based Value
The Multiples-Based Value for
Capricor Therapeutics Inc (4LN2) under the Base Case is 6.42 EUR.
Compared with the current market price of 24.98 EUR, the stock appears
Overvalued by 74% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.